tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

KALV Stock Latest News

KalVista presents data showing sebetralstat effectiveness in reducing anxiety
The FlyKalVista presents data showing sebetralstat effectiveness in reducing anxiety
2d ago
KALV
KalVista reports inducement grants under Nasdaq listing rule
PremiumThe Fly
KalVista reports inducement grants under Nasdaq listing rule
5d ago
KALV
KalVista submits additional MAAs for sebetralstat for treatment of HAE
PremiumThe Fly
KalVista submits additional MAAs for sebetralstat for treatment of HAE
7d ago
KALV
KalVista initiated with a Buy at JonesResearch
PremiumThe Fly
KalVista initiated with a Buy at JonesResearch
10d ago
KALV
PHVS
KalVista Pharmaceuticals Welcomes New CFO for Future Growth
PremiumCompany Announcements
KalVista Pharmaceuticals Welcomes New CFO for Future Growth
27d ago
8K
KALV
KalVista names Brian Piekos as CFO
PremiumThe FlyKalVista names Brian Piekos as CFO
27d ago
ELTX
KALV
KalVista presents sebetralstat data at Bradykinin Symposium 2024
Premium
The Fly
KalVista presents sebetralstat data at Bradykinin Symposium 2024
1M ago
KALV
KalVista reports Q1 EPS (87c), consensus (91c)
Premium
The Fly
KalVista reports Q1 EPS (87c), consensus (91c)
1M ago
KALV
KalVista announces FDA approval of NDA for sebetralstat
PremiumThe Fly
KalVista announces FDA approval of NDA for sebetralstat
1M ago
KALV
Is KALV a Buy, Before Earnings?
PremiumPre-Earnings
Is KALV a Buy, Before Earnings?
1M ago
KALV
KalVista’s sebetralstat application validated by European Medicines Agency
PremiumThe Fly
KalVista’s sebetralstat application validated by European Medicines Agency
2M ago
KALV
3 Best Stocks to Buy Now, 7/30/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 7/30/2024, According to Top Analysts
2M ago
SYM
KALV
KalVista files $300M mixed securities shelf
PremiumThe FlyKalVista files $300M mixed securities shelf
3M ago
KALV
KalVista reports Q1 EPS ($1.02), consensus (73c)
Premium
The Fly
KalVista reports Q1 EPS ($1.02), consensus (73c)
3M ago
KALV
KalVista reports inducement grants under Nasdaq listing rule
Premium
The Fly
KalVista reports inducement grants under Nasdaq listing rule
3M ago
KALV
Is KALV a Buy, Before Earnings?
PremiumPre-Earnings
Is KALV a Buy, Before Earnings?
3M ago
KALV
KalVista begins trial for sebetralstat in children with hereditary angioedema
PremiumThe Fly
KalVista begins trial for sebetralstat in children with hereditary angioedema
3M ago
KALV
KalVista submits New Drug Application to FDA for sebetralstat
PremiumThe Fly
KalVista submits New Drug Application to FDA for sebetralstat
4M ago
KALV
KalVista presents data on persisting unmet needs in Hereditary Angioedema
PremiumThe Fly
KalVista presents data on persisting unmet needs in Hereditary Angioedema
4M ago
KALV
KalVista announces publication of data from Phase 3 KONFIDENT trial
PremiumThe FlyKalVista announces publication of data from Phase 3 KONFIDENT trial
4M ago
KALV
KalVista price target lowered to $20 from $24 at H.C. Wainwright
Premium
The Fly
KalVista price target lowered to $20 from $24 at H.C. Wainwright
5M ago
KALV
KalVista Pharmaceuticals Welcomes New Board Member
Premium
Company Announcements
KalVista Pharmaceuticals Welcomes New Board Member
6M ago
8K
KALV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >